Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 3Completed 3Recruiting 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 3Colorectal Neoplasms 3Pancreatic Neoplasms 1Liver Metastasis Colon Cancer 1Colonic Neoplasms 1

Interventions

Oxaliplatin 47Capecitabine 46Fluorouracil 40Leucovorin 30Radiotherapy 25Irinotecan 20Chemoradiotherapy 14Bevacizumab 14Cetuximab 12Neoadjuvant Therapy 11Folfox protocol 11Chemotherapy, Adjuvant 11Laparoscopy 10XELOX 9Drug Therapy 9Surgical Procedures, Operative 6Robotic Surgical Procedures 5Radiation 5Mastectomy, Segmental 5Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Panitumumab 4Gemcitabine 4durvalumab 3Simvastatin 3Magnetic Resonance Spectroscopy 3Indocyanine Green 3FOLFOXIRI protocol 3tislelizumab 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Rectal Neoplasms × FOLFOXIRI protocol × Clear all
NCT05081687 2023-10-11

BRAZIL-TNT

Hospital Israelita Albert Einstein

Phase 3 Unknown
150 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT03484221 2021-04-14

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

China Medical University, China

Phase 2 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02942563 2018-01-03

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

RenJi Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡